Venous thromboembolism - apixaban (hip and knee surgery): review decision March 2015 information
History
A list of downloadable documents created during development.
Background information
Venous thromboembolism - apixaban (hip and knee surgery): equality impact assessment - guidance development
Venous thromboembolism - apixaban (hip and knee surgery): final appraisal determination
-
Venous thromboembolism - apixaban (hip and knee surgery): final appraisal determination information
-
-
Venous thromboembolism - apixaban (hip and knee surgery): evaluation report
-
Venous thromboembolism - apixaban (hip and knee surgery): pre-meeting briefing (PDF 532 KB)
-
Venous thromboembolism - apixaban (hip and knee surgery): Evidence Review Group report (PDF 1.41 MB)
-
-
-
Venous thromboembolism - apixaban (hip and knee surgery): clarifcation
-
Venous thromboembolism - apixaban (hip and knee surgery): NICE clarification letter (PDF 99 KB)
-
-
Venous thromboembolism - apixaban (hip and knee surgery): patient group, professional group and NHS organisation submission statements
-
Venous thromboembolism - apixaban (hip and knee surgery): NHS Warwickshire (PDF 68 KB)
-
Venous thromboembolism - apixaban (hip and knee surgery): Royal College of Anaesthetists (PDF 57 KB)
-
Venous thromboembolism - apixaban (hip and knee surgery): expert written personal statements
-
Venous thromboembolism - apixaban (hip and knee surgery): Dr Raza Alikhan (PDF 75 KB)
-
Venous thromboembolism - apixaban (hip and knee surgery): Annya Stephens-Boal (PDF 108 KB)
-
Venous thromboembolism - apixaban (hip and knee surgery): AntiCoagulation Europe (ACE) (PDF 91 KB)
-